Your browser doesn't support javascript.
loading
Inflammation promotes resistance to immune checkpoint inhibitors in high microsatellite instability colorectal cancer.
Sui, Qiaoqi; Zhang, Xi; Chen, Chao; Tang, Jinghua; Yu, Jiehai; Li, Weihao; Han, Kai; Jiang, Wu; Liao, Leen; Kong, Lingheng; Li, Yuan; Hou, Zhenlin; Zhou, Chi; Zhang, Chenzhi; Zhang, Linjie; Xiao, Binyi; Mei, Weijian; Xu, Yanbo; Qin, Jiayi; Zheng, Jian; Pan, Zhizhong; Ding, Pei-Rong.
Afiliação
  • Sui Q; Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.
  • Zhang X; State Key Laboratory of Oncology in South China, Guangzhou, 510060, P. R. China.
  • Chen C; Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, P. R. China.
  • Tang J; BGI-Shenzhen, Shenzhen, 518120, P. R. China.
  • Yu J; Department of Thoracic Surgery, Peking University Shenzhen Hospital; Shenzhen Peking University-The Hong Kong University of Science and Technology Medical Center, Shenzhen, 518035, P. R. China.
  • Li W; Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.
  • Han K; State Key Laboratory of Oncology in South China, Guangzhou, 510060, P. R. China.
  • Jiang W; Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, P. R. China.
  • Liao L; Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.
  • Kong L; State Key Laboratory of Oncology in South China, Guangzhou, 510060, P. R. China.
  • Li Y; Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, P. R. China.
  • Hou Z; Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.
  • Zhou C; State Key Laboratory of Oncology in South China, Guangzhou, 510060, P. R. China.
  • Zhang C; Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, P. R. China.
  • Zhang L; Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.
  • Xiao B; State Key Laboratory of Oncology in South China, Guangzhou, 510060, P. R. China.
  • Mei W; Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, P. R. China.
  • Xu Y; Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.
  • Qin J; State Key Laboratory of Oncology in South China, Guangzhou, 510060, P. R. China.
  • Zheng J; Collaborative Innovation Center for Cancer Medicine, Guangzhou, 510060, P. R. China.
  • Pan Z; Department of Colorectal Surgery, Sun Yat-sen University Cancer Center, Guangzhou, 510060, P. R. China.
  • Ding PR; State Key Laboratory of Oncology in South China, Guangzhou, 510060, P. R. China.
Nat Commun ; 13(1): 7316, 2022 11 28.
Article em En | MEDLINE | ID: mdl-36443332

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Inibidores de Checkpoint Imunológico Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2022 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Neoplasias Colorretais / Inibidores de Checkpoint Imunológico Tipo de estudo: Observational_studies / Prognostic_studies / Risk_factors_studies Limite: Humans Idioma: En Revista: Nat Commun Assunto da revista: BIOLOGIA / CIENCIA Ano de publicação: 2022 Tipo de documento: Article